The resignations are in protest over the agency's decision to approve Biogen Inc's Alzheimer's treatment despite the committee's recommendation against doing so.
Posted by UE editors
Click to copy the Short Url to this post:
The Whole Web on a Single Page, for People Who Love Good Reads. Join Now →